SCHEMBL6597674

SCHEMBL6597674

c1ccc(Cc2cc(-c3cccnc3)[nH]n2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGDS O60760 1/20 0.53
CYP3A4 P08684 4/20 0.50
ALDH1A1 P00352 3/20 0.50
CYP11B1 P15538 3/20 0.50
CYP11B2 P19099 3/20 0.50
CYP1A2 P05177 2/20 0.50
CYP2A6 P11509 4/20 0.45
CYP2B6 P20813 4/20 0.45
CYP2E1 P05181 3/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
HSD17B10 Q99714 2/20 0.45
KDM4E B2RXH2 1/20 0.45
CYP19A1 P11511 1/20 0.43
EPHX2 P34913 1/20 0.42
PRMT6 Q96LA8 1/20 0.42
CYP2D6 P10635 4/20 0.42
CLK4 Q9HAZ1 1/20 0.42
BTK Q06187 1/20 0.42
CYP2C9 P11712 3/20 0.42
CYP2C19 P33261 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1194018 0.99 HPGDS (0.52) HPGDSCYP3A4ALDH1A1CYP11B1CYP11B2
SCHEMBL28114539 0.86 RAB9A (0.53) HPGDSALDH1A1SMN1; SMN2HSD17B10KDM4E
SCHEMBL2317822 0.80 CYP3A4 (0.54) HPGDSCYP3A4ALDH1A1CYP1A2CYP2A6
SCHEMBL6596371 0.79 HPGDS (0.53) HPGDSCYP3A4ALDH1A1CYP1A2CYP2A6
Hydrochloric Acid SCHEMBL1195021 0.78 HPGDS (0.52) HPGDSCYP3A4ALDH1A1CYP1A2CYP2A6
SCHEMBL27730924 0.76 HPGDS (0.78) HPGDSCYP3A4ALDH1A1CYP1A2CYP2A6
SCHEMBL7379027 0.76 CYP1A2 (0.50) HPGDSCYP3A4ALDH1A1CYP1A2CYP2A6
SCHEMBL25336331 0.76 MKNK2 (0.43) CYP3A4ALDH1A1SMN1; SMN2HSD17B10KDM4E
SCHEMBL27789789 0.76 RAB9A (0.46) HPGDSALDH1A1SMN1; SMN2
Hydrochloric Acid SCHEMBL27514609 0.75 HPGDS (0.76) HPGDSCYP3A4ALDH1A1CYP1A2CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1373263-B1 HETEROCYCLIC COMPOUNDS FOR AGING-RELATED AND DIABETIC VASCULAR COMPLICATIONS TORRENT PHARMACEUTICALS LTD (IN) 2004-10-27 EP claimed